Clin Infect Dis

1. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
   Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
   Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
   

   >> Share

   
   
2. MORGAN H, Ndjeka N, Hasan T, Gegia M, et al
   Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
   Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093.
   

   >> Share

   
   

   
   Emerg Infect Dis

3. FUKUNAGA R, Pierre P, Williams JK, Briceno-Robaugh R, et al
   Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
   Emerg Infect Dis. 2024;30:1-5.
   

   >> Share

   
   
4. DAHL VN, Butova T, Rosenthal A, Grinev A, et al
   Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022.
   Emerg Infect Dis. 2024;30:831-833.
   

   >> Share

   
   

   
   Eur J Clin Microbiol Infect Dis

5. CHEN Y, Liu J, Zhang Q, Chen H, et al
   Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
   Eur J Clin Microbiol Infect Dis. 2024;43:747-765.
   

   >> Share

   
   

   
   J Infect Dis

6. PATON NI, Gurumurthy M, Lu Q, Leek F, et al
   Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
   J Infect Dis. 2024 Mar 25:jiae104. doi: 10.1093.
   

   >> Share

   
   
7. OLSSON O, Sokilde R, Tesfaye F, Karlson S, et al
   Tuberculosis disease is associated with elevated plasma ribonuclease activity in antiretroviral treatment-naive people with HIV.
   J Infect Dis. 2024 Mar 25:jiae143. doi: 10.1093.
   

   >> Share

   
   

   
   Lancet

8. BURKI T
   Pivotal tuberculosis vaccine trial begins.
   Lancet. 2024;403:1125.
   

   >> Share

   
   
9. BHARGAVA A, Bhargava M, Pai M
   Tuberculosis: a biosocial problem that requires biosocial solutions.
   Lancet. 2024 Mar 20:S0140-6736(24)00489-6. doi: 10.1016/S0140-6736(24)00489.
   

   >> Share

   
   

   
   PLoS One

10. JOBARTEH T, Otu J, Gitteh E, Mendy FS, et al
    The use of Kudoh method for culture of Mycobacterium tuberculosis and Mycobacterium africanum in The Gambia.
    PLoS One. 2024;19:e0300042.
    

    >> Share

    
    
11. PADHI A, Agarwal A, Bhise M, Chaudhary A, et al
    Progress and challenges in achieving tuberculosis elimination in India by 2025: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0301060.
    

    >> Share

    
    
12. MUNSHI T, Gupta A, Evangelopoulos D, Guzman JD, et al
    Correction: Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0301375.
    

    >> Share

    
    
13. PETRUCCIANI A, Hoerter A, Kotze L, Du Plessis N, et al
    In silico agent-based modeling approach to characterize multiple in vitro tuberculosis infection models.
    PLoS One. 2024;19:e0299107.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

14. DATTA M, Via LE, Dartois V, Weiner DM, et al
    Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits.
    Proc Natl Acad Sci U S A. 2024;121:e2321336121.
    

    >> Share

    
    
15. FORTUNE SM
    The Titanic question in TB control: Should we worry about the bummock?
    Proc Natl Acad Sci U S A. 2024;121:e2403321121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share